Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
During the dose escalation phase, the purpose of the study is to determine the maximum tolerated dose (MTD) of CHR-3996 and tosedostat administered in combination in subjects with relapsed or refractory multiple myeloma. In the dose expansion phase the purpose of the study is to determine the safety profile of CHR-3996 and tosedostat administered in combination and to estimate the response rate.
Critère d'inclusion
- Relpsed or refractory multiple myeloma